一个案例报告:在帕金森病中,结合后部下丘脑区域和内部白色球体的深度大脑刺激
Qi Deng1,2, Yanghong Zou1,2, Yingwang Yuan1,2
1The Second Department of Neurosurgery, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Frontiers in human neuroscience
|August 13, 2025
概括
这项研究探讨了联合深度大脑刺激 (DBS),针对晚期帕金森病 (PD) 的后部下丘脑区域 (PSA) 和内球体 (GPi). 综合方法有效地管理了患者的不对称运动症状,显示出明显的改善.
科学领域:
- 神经外科 神经外科
- 神经学 神经学
- 运动障碍 运动障碍
背景情况:
- 深度大脑刺激 (DBS) 是高级帕金森病 (PD) 的关键手术治疗方法.
- 内部白色球体 (GPi) 和后部亚thalamic区域 (PSA) 是已确立的DBS目标.
- 结合的GPi和PSA DBS在临床研究中以前没有被研究过.
研究的目的:
- 为了研究结合DBS的有效性,针对GPi和PSA在患有晚期PD的患者中.
- 评估这种综合方法对运动症状和疾病进展的影响.
主要方法:
- 一个单一的病例报告,报告了具有不对称症状的高级PD病例.
- 双边DBS植入:左半球准PSA,右半球准GPi.
- 使用UPDRS-III分数和Hoehn-Yahr (H-Y) 阶段进行运动功能的术后评估.
主要成果:
- 患者在UPDRS-III得分显著降低 (73到46,改善了约37%).
- 霍恩-雅尔阶段从4个改善到2.5个 (~37.5%的改善).
- 在6个月的随访期间,有效控制PD症状,没有重大不良影响.
结论:
- 结合GPi和PSA DBS是一种潜在的治疗方法,用于患有不对称运动症状的晚期PD患者.
- 这种方法为管理复杂的PD呈现提供了可行的选择.
- 需要进一步的临床研究来验证这些发现.
更多相关视频
07:14A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
Published on: May 31, 2016
14.9K
14:14Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
Published on: August 12, 2018
9.0K
相关概念视频
01:24Parkinson's Disease: Treatment
380
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
380
01:15Parkinson's Disease: Overview
704
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
704